English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Molecular characterisation of spreading depression-induced preconditioning

Obrenovitch, T. P., Schepers, C., Godukhin, A., Wachtel, A., Urenjak, J., Nietfeld, W., et al. (2002). Molecular characterisation of spreading depression-induced preconditioning. In J. Krieglstein (Ed.), Pharmacology of Cerebral Ischemia (pp. 37-47). Stuttgart: Scientific Publishers.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-0010-8CBC-7 Version Permalink: http://hdl.handle.net/11858/00-001M-0000-0010-8CBD-5
Genre: Book Chapter

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Obrenovitch, T. P., Author
Schepers, C., Author
Godukhin, A., Author
Wachtel, A., Author
Urenjak, J., Author
Nietfeld, Wilfried1, Author              
Chazot, P. L., Author
Affiliations:
1Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433550              

Content

show
hide
Free keywords: Preconditioning; tolerance to ischemia; spreading depression; gene expression; glutamate receptors; nicotinic receptors
 Abstract: Preconditioning refers to the adaptative cytoprotection that can be induced by a variety of sublethal insults (e.g. a short period of hypoxia) and which increases the brain resistance to a subsequent, potentially lethal insult (e.g. severe ischemia). This fundamental biological process provides an alternative scientific rationale and strategy for the discovery of effective neuroprotective strategies. Our objective is to identify the biological determinants of increased tolerance through the determination of changes in gene expression and protein profiles at several time points after induction of preconditioning. We are focusing on preconditioning induced by repetitive cortical spreading depression (CSD), because this stimulus allows the preparation of large samples of mouse cortex that are preconditioned evenly and consistently. Differential genomics at time points 1, 3 and 6 h post CSD revealed significant changes in the expression of a large number of genes, among which 178 possible candidates had their expression changed by > 100 folds during this period. A high degree of correlation was found between the 3 time points, indicating good experimental reproducibility, but a further evaluation of the candidate genes is still required. Only a few selected proteins were examined by Western blot analysis, 24 h after CSD. New findings include significant changes in immunoreactivity for the glutamate AMPA receptor GluR1 and GluR2 subunits, and especially a 15-fold increase in that of the a7 nicotinic acetylcholine receptor (a7 nAChR) subunit.

Details

show
hide
Language(s): eng - English
 Dates: 2002
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: eDoc: 29177
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Pharmacology of Cerebral Ischemia
Source Genre: Book
 Creator(s):
Krieglstein, Josef, Editor
Affiliations:
-
Publ. Info: Stuttgart : Scientific Publishers
Pages: - Volume / Issue: - Sequence Number: - Start / End Page: 37 - 47 Identifier: -